Behrad Derakhshan
Chief Business Officer · Edgewise Therapeutics, Inc.
- 2025
- Aug 17, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Behrad Derakhshan files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Alan J. Russell - $10.25M in EWTX purchases and sales in the last 12 months
- Joanne M. Donovan - $4.62M in EWTX purchases and sales in the last 12 months
- Badreddin Edris - $3.40M in EWTX purchases and sales in the last 12 months
- Kevin Koch - $785K in EWTX purchases and sales in the last 12 months
- John R. Moore - $220K in EWTX purchases and sales in the last 12 months
- Jonathan C. Fox - $199K in EWTX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Behrad Derakhshan?
Behrad Derakhshan is a corporate insider, tracked as Chief Business Officer of Edgewise Therapeutics, Inc. (EWTX). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Behrad Derakhshan submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Behrad Derakhshan been buying or selling stock?
Recorded transactions: 0 open-market purchases and 5 open-market sales ($257K) across all tracked filings.
